Apollon Wealth Management LLC Acquires 949 Shares of Axon Enterprise, Inc $AXON

Apollon Wealth Management LLC raised its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 47.0% during the second quarter, HoldingsChannel reports. The fund owned 2,967 shares of the biotechnology company’s stock after purchasing an additional 949 shares during the quarter. Apollon Wealth Management LLC’s holdings in Axon Enterprise were worth $2,456,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also bought and sold shares of AXON. Jennison Associates LLC raised its holdings in Axon Enterprise by 23,203.7% during the 1st quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock valued at $322,961,000 after acquiring an additional 611,418 shares during the period. Nuveen LLC bought a new stake in Axon Enterprise during the 1st quarter valued at $264,796,000. McElhenny Sheffield Capital Management LLC bought a new stake in Axon Enterprise during the 2nd quarter valued at $255,833,000. Westfield Capital Management Co. LP raised its holdings in Axon Enterprise by 29.8% during the 1st quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after acquiring an additional 212,931 shares during the period. Finally, Vanguard Group Inc. raised its holdings in Axon Enterprise by 2.2% during the 1st quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock valued at $4,540,005,000 after acquiring an additional 185,571 shares during the period. Institutional investors own 79.08% of the company’s stock.

Wall Street Analysts Forecast Growth

AXON has been the topic of a number of analyst reports. Northland Securities set a $800.00 target price on shares of Axon Enterprise in a report on Tuesday, August 5th. Craig Hallum raised shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price target on the stock in a report on Tuesday, August 5th. Bank of America upped their price target on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Axon Enterprise in a report on Wednesday, October 8th. Finally, JPMorgan Chase & Co. upped their price target on shares of Axon Enterprise from $730.00 to $850.00 and gave the stock an “overweight” rating in a report on Thursday, July 17th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $841.64.

Axon Enterprise Trading Down 4.2%

Axon Enterprise stock opened at $703.03 on Monday. The stock has a market cap of $55.19 billion, a P/E ratio of 173.59, a PEG ratio of 27.30 and a beta of 1.41. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. Axon Enterprise, Inc has a fifty-two week low of $422.38 and a fifty-two week high of $885.91. The firm’s fifty day moving average price is $755.57 and its 200-day moving average price is $714.84.

Axon Enterprise (NASDAQ:AXON) last released its earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.58. The business had revenue of $668.54 million for the quarter, compared to analysts’ expectations of $641.77 million. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm’s revenue was up 32.6% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. Equities research analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, President Joshua Isner sold 15,919 shares of the stock in a transaction on Friday, August 15th. The stock was sold at an average price of $746.26, for a total value of $11,879,712.94. Following the transaction, the president owned 238,379 shares of the company’s stock, valued at $177,892,712.54. This represents a 6.26% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction on Monday, August 11th. The shares were sold at an average price of $831.29, for a total value of $8,312,900.00. Following the completion of the transaction, the chief executive officer directly owned 3,053,982 shares in the company, valued at approximately $2,538,744,696.78. This represents a 0.33% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 59,932 shares of company stock valued at $45,115,616 over the last quarter. Insiders own 4.40% of the company’s stock.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.